Benitec Biopharma Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 556K | 0 | 0 | 0 | -6K |
| Cost of Goods Sold | 119K | 120K | 118K | 278K | 106K | 81K | 91K | 15K |
| Gross Profit | -119K | -120K | -118K | 278K | -106K | -81K | -91K | -21K |
| R&D Expenses | 6.3M | 5.8M | 3.4M | 3.7M | 6.5M | 5.4M | 3.6M | 3.5M |
| Operating Expenses | 13.5M | 13.4M | 9.8M | 17.2M | 15.3M | 10.8M | 5.8M | 5.5M |
| Operating Income | -13.6M | -13.4M | -9.8M | -17.2M | -15.3M | -10.8M | -5.8M | -5.5M |
| Other Income / Gains | 1.6M | 1.5M | 838K | 1.0M | 834K | 1.3M | 732K | 828K |
| Net Income | -11.9M | -11.8M | -9.0M | -16.1M | -14.5M | -9.6M | -5.1M | -4.7M |
| EPS (Diluted) | -0.24 | -0.26 | -0.22 | -0.39 | -0.38 | -0.33 | -0.48 | -0.53 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0.50 | 0 | 0 | 0 | 3.50 |
| General And Administrative Expenses | 7.3M | 7.5M | 6.4M | 13.5M | 8.8M | 5.4M | 2.2M | 2.0M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 7.3M | 7.5M | 6.4M | 13.5M | 8.8M | 5.4M | 2.2M | 2.0M |
| Other Expenses | -119K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 13.6M | 13.4M | 9.8M | 17.2M | 15.3M | 10.8M | 5.8M | 5.5M |
| Interest Income | 1.6M | 0 | 0 | 0 | 823K | 823K | 0 | 920K |
| Interest Expense | 0 | -1.4M | -1.0M | -1.0M | 0 | 0 | -604K | 0 |
| Depreciation And Amortization | 119K | 120K | 118K | 118K | 106K | 81K | 91K | 91K |
| Ebitda | -13.5M | -13.3M | -9.7M | -17.1M | -15.2M | -10.7M | -5.7M | -5.4M |
| Ebitdaratio | 0 | 0 | 0 | -30.68 | 0 | 0 | 0 | 897.333 |
| Operating Income Ratio | 0 | 0 | 0 | -30.892 | 0 | 0 | 0 | 924.667 |
| Income Before Tax | -11.9M | -11.8M | -9.0M | -16.1M | -14.5M | -9.6M | -5.1M | -4.7M |
| Income Before Tax Ratio | 0 | 0 | 0 | -29.041 | 0 | 0 | 0 | 786.667 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | -29.041 | 0 | 0 | 0 | 786.667 |
| Epsdiluted | -0.24 | -0.26 | -0.22 | -0.39 | -0.38 | -0.33 | -0.48 | -0.53 |
| Weighted Average Shs Out | 49.4M | 46.0M | 41.5M | 36.2M | 38.6M | 22.1M | 10.6M | 10.1M |
| Weighted Average Shs Out Dil | 49.4M | 46.0M | 41.5M | 36.2M | 38.6M | 22.1M | 10.6M | 10.1M |